AI in Healthcare | What Comes Next Ep.5

“Every single year, the world’s total AI brainpower becomes about 3.3 times bigger than it was the year before. In 2025, the world had roughly 17 million H100-equivalent GPUs of AI compute capacity, and by the end of 2026 this is projected to reach about 50 million H100-equivalent GPUs.”

Nvidia CEO Jensen Huang argues the company’s true moat is its supply chain lock-in and CUDA ecosystem, not chip specs alone, with nearly $100B in purchase commitments upstream and hundreds of millions of GPUs in global install base. He pushes back hard on AI chip export controls to China, warning the US risks ceding the world’s second largest AI market. For payer and provider leaders, Huang’s framing of AI infrastructure as a multi-year, multi-layer commitment mirrors the vendor lock-in dynamics now playing out in health system cloud and AI contracting. Dwarkesh Podcast

Anthropic captured 37% of business generative AI spending in Q1 2026, surpassing OpenAI at 33%, according to Ramp corporate card data. OpenAI still leads in overall adoption at 81% of AI buyers versus Anthropic’s 63%, but Anthropic is gaining fast, driven by Claude Code, Cowork, and its ability to sell to less technical users. More than half of Ramp customers now pay for AI, up from 18% two years ago. For payer and provider leaders, Anthropic’s enterprise momentum signals that foundation model vendor selection is becoming a strategic decision with real market share implications. Sherwood News

Anthropic released Claude Opus 4.7, delivering a 13% lift in coding task resolution over Opus 4.6, 3x better vision resolution supporting images up to 2,576 pixels, and state-of-the-art performance on finance, legal, and document reasoning benchmarks. The model ships with built-in cyber safeguards, a first test of safety controls ahead of a broader Mythos-class release. Pricing holds at $5 per million input / $25 per million output tokens. For payer and provider leaders deploying AI agents in clinical documentation, coding, or prior auth workflows, Opus 4.7 represents a meaningful reliability upgrade for long-running autonomous tasks. Anthropic

Snap announced layoffs affecting 1,000 employees, or 16% of its full-time workforce, plus closure of 300+ open roles, targeting more than $500M in annualized cost reduction by H2 2026. CEO Evan Spiegel explicitly cited AI as enabling small squads to drive meaningful progress across ad platforms, infrastructure, and product initiatives previously requiring larger teams. For payer and provider leaders, Snap is an early and visible data point in a pattern that will reach healthcare operations: AI-enabled workforce restructuring is no longer theoretical. Snap Newsroom

Stanford HAI’s 2026 AI Index reports global corporate AI investment hit $581.7B, up 130% year over year, while US AI talent inflows dropped 89% since 2017. AI agent success on real-world tasks surged from 20% to 77% in one year. Entry-level software developer employment fell nearly 20% since 2024. In healthcare, clinical note tools cut documentation time by up to 83%, but only 5% of clinical AI studies used real patient data. For payer and provider leaders, the Index confirms AI adoption is accelerating faster than governance, measurement, or workforce planning. Stanford HAI

Trumed, a startup featured on Bloomberg, is allowing Americans to use HSA and FSA funds for gym memberships, sleep aids, and scientifically vetted supplements, expanding the definition of eligible preventive health spending. CEO Justin Mares argues the future of healthcare is prevention over treatment, with strict scientific vetting filtering out unproven products. For payer leaders, this signals growing consumer and employer appetite for benefit designs that fund upstream wellness, adding pressure on plan architects to broaden what counts as covered preventive care. Bloomberg

Blue Shield of California’s Virtual Blue plan, launched in 2023 with Accolade and TeleMed2U, has surpassed 150,000 members while delivering a 7% to 10% reduction in overall cost of care and often same-day access with $0 out-of-pocket costs for virtual visits. The plan gives members access to virtual primary care, behavioral health, and specialist services alongside Blue Shield’s full PPO network. For payer leaders, Virtual Blue is a live proof point that virtual-first plan design can bend the cost curve without sacrificing network breadth or member satisfaction. Fierce Healthcare

CMS published a proposed rule on April 14 extending its 2024 Interoperability and Prior Authorization Final Rule to cover drug prior authorizations, requiring payers to respond to standard requests within 7 calendar days and expedited requests within 72 hours. The rule mandates adoption of HL7 FHIR-based APIs for electronic drug prior auth by October 2027 and public reporting of authorization metrics. CMS projects the broader prior auth reforms will save $15B over 10 years in administrative costs. For payer leaders, this is an operational transformation deadline, not a future-state policy discussion. Regulations.gov

OpenAI launched GPT-Rosalind, a frontier reasoning model built for biology, drug discovery, and translational medicine, available in research preview to qualified enterprise customers including Amgen, Moderna, Thermo Fisher, and the Allen Institute. The model handles multi-step scientific workflows spanning literature synthesis, hypothesis generation, and experimental planning, with access to 50+ scientific databases. Drug discovery AI investment is projected to reach $2.51B in 2026 and $16.49B by 2034. For provider and payer leaders, this signals AI moving from administrative tools into hard clinical science, compressing drug development timelines and reshaping R&D economics. OpenAI

OpenAI’s Chief Economist released a framework analyzing 900+ occupations covering 99.7% of U.S. employment, finding that 18% of jobs face high near-term automation risk, 24% will reorganize, 12% will grow, and 46% face little immediate change. ChatGPT usage is 3x higher in at-risk occupations versus safer ones. Critically, AI exposure alone does not predict job loss: regulation, physical presence, and relational trust keep humans central in many high-exposure roles. For payer and provider leaders, nursing and clinical roles score high on human necessity, but administrative and documentation-heavy roles face real near-term pressure. OpenAI

A West Health-Gallup poll found roughly one quarter of U.S. adults used an AI tool for health information in the past 30 days, with 7 in 10 citing a desire for quick answers. A smaller but significant group turned to AI because care was too expensive, inconvenient, or unavailable outside business hours. About 3 in 10 did not want to pay for a doctor’s visit. For payer and provider leaders, AI is already functioning as an informal front door to care, and patients arriving with AI-informed questions are reshaping the expectations placed on clinical encounters. PBS NewsHour

A landmark JAMA study across five academic health systems and 8,581 clinicians found AI scribes reduced EHR time by 13 minutes and documentation time by 16 minutes per day, enabling 0.5 additional patient visits per week. Critically, clinicians using scribes for more than 50% of encounters saw twice the EHR reduction and three times the documentation savings, yet only 32% of users adopted at that frequency. For provider leaders, the data reframes AI scribe ROI as an adoption intensity problem, not a technology problem. Healthcare IT News

The Massachusetts Health Policy Commission found that Mass General Brigham’s proposed affiliation with CVS MinuteClinic could create capacity for 120,000 adult primary care patients across 37 retail locations, but projects a $40.2M annual increase in commercial spending by year three. The deal would fold MinuteClinic into MGB’s ACO and payer contracts, raising concerns about MGB gaining additional pricing leverage. Children would lose access to convenience care entirely under the proposed model. For provider and payer leaders, this is a preview of the retail-health-to-ACO integration playbook and its cost consequences. Mass HPC

Ten vital signs tracking the structural state of U.S. healthcare as of April 2026. Each indicator is sourced from federal data releases and updated monthly.

Data Vintage: Verified April 2026 Reporting • Prepared for Executive Insight • Sources: BLS, CMS, Census, NHE, FAIR Health, CDC, Aon.